This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Life Technologies Begins Shipping QuantStudio™ 3D Digital PCR System

CARLSBAD, Calif., June 10, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announces it has begun commercial shipments of the QuantStudio™ 3D Digital PCR System, the first chip-based instrument designed for this rapidly growing segment of the genetic analysis market. Featuring the simplest workflow and smallest footprint available on the market, the benchtop platform is designed for experiments requiring absolute quantification of targeted DNA molecules and disruptively priced at $39,000 to enable broad accessibility to all laboratories.

Scientists worldwide commonly use real-time PCR (polymerase chain reaction) to amplify and quantify nucleic acids. A variation of that powerful technology, digital PCR goes beyond the limits of real-time PCR and provides absolute quantification of DNA samples, making the application ideally suited for accurately detecting rare genetic mutations important in cancer or infectious diseases.

"Good research depends on three things: researchers' techniques, appropriate funding and sample quality. Compared to in-situ hybridization methods, digital PCR has a direct impact on these components," said Bruno Ping, senior biomedical scientist, Royal Surrey County Hospital in the U.K. "The great advantage of the QuantStudio 3D is that it makes copy number variation research, for example, more readily available and cost effective as you are able to probe a higher number of samples at lower price points. The data achieved in my lab correlate well with our previous results."

The QuantStudio™ 3D Digital PCR System is designed to be affordable and easy to use for a wide variety of laboratory settings.  The simple workflow, combined with the system's chip-based approach, reduces the number of required hands-on steps to begin experiments – reducing the risk of sample contamination and loss of DNA normally associated with droplet-based systems on the market. Once a sample has been loaded onto the chip, the system takes less than one minute to return initial data.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs